1. Home
  2. CWD vs XAIR Comparison

CWD vs XAIR Comparison

Compare CWD & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CaliberCos Inc.

CWD

CaliberCos Inc.

HOLD

Current Price

$1.22

Market Cap

10.0M

Sector

Finance

ML Signal

HOLD

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$0.47

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWD
XAIR
Founded
2009
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
10.1M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
CWD
XAIR
Price
$1.22
$0.47
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
86.7K
214.8K
Earning Date
05-14-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.09
EPS
N/A
N/A
Revenue
$20,097,000.00
$3,705,000.00
Revenue This Year
N/A
$122.00
Revenue Next Year
$19.17
$58.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
219.67
52 Week Low
$0.20
$0.15
52 Week High
$46.21
$3.78

Technical Indicators

Market Signals
Indicator
CWD
XAIR
Relative Strength Index (RSI) 54.17 24.40
Support Level $1.15 $0.15
Resistance Level $1.55 $1.25
Average True Range (ATR) 0.12 0.07
MACD 0.03 -0.02
Stochastic Oscillator 73.75 3.07

Price Performance

Historical Comparison
CWD
XAIR

About CWD CaliberCos Inc.

CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Share on Social Networks: